Cargando…

Early clinical response and presence of viral resistant minority variants: a proof of concept study

INTRODUCTION: Traditional genotyping assays detect viral variants present in at least 15–25% of the entire virus population. We tested the Next generation GS Junior System (NGS) setted with a detection limit of 0.05% and evaluated the clinical relevance of low prevalent mutations. METHODS: NGS was p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Callegaro, Annapaola, Di Filippo, Elisa, Astuti, Noemi, Andrea Serna Ortega, Paula, Rizzi, Marco, Farina, Claudio, Valenti, Daniela, Maggiolo, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P227
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225251/ https://www.ncbi.nlm.nih.gov/pubmed/25397504 http://dx.doi.org/10.7448/IAS.17.4.19759

Ejemplares similares

Long-term effect of a four-drugs induction regimen for patients with high baseline viral load
por: Maggiolo, Franco, et al.
Publicado: (2014)

Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status
por: Maggiolo, Franco, et al.
Publicado: (2014)

Morphée généralisée post-vaccin anti-COVID-19
por: El Kissouni, A., et al.
Publicado: (2022)

Reduced adherence to antiretroviral therapy is associated with residual low-level viremia
por: Maggiolo, Franco, et al.
Publicado: (2017)

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
por: Costarelli, Silvia, et al.
Publicado: (2014)

Single-Tablet Regimens in HIV Therapy
por: Astuti, Noemi, et al.
Publicado: (2014)

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Patient preferences for characteristics of antiretroviral therapies: results from five European countries
por: Gazzard, Brian, et al.
Publicado: (2014)

Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
por: Maggiolo, Franco, et al.
Publicado: (2022)

Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
por: Maggiolo, Franco, et al.
Publicado: (2017)

Adherence to and Forgiveness of 3TC/DTG in a Real-World Cohort
por: Maggiolo, Franco, et al.
Publicado: (2022)

Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide
por: Maggiolo, Franco, et al.
Publicado: (2022)

Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXA
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Single-tablet regimens (STRs) enhance patients’ acceptability of HAART
por: Maggiolo, F, et al.
Publicado: (2012)

Among once-daily regimens, single tablet regimens (STRs) are associated with better adherence
por: Murri, R, et al.
Publicado: (2012)

Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
por: Maggiolo, Franco, et al.
Publicado: (2015)

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study
por: Jesús Pérez Elías, María, et al.
Publicado: (2014)

CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily
por: Tiraboschi, Juan, et al.
Publicado: (2014)

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART
por: Fidler, Sarah, et al.
Publicado: (2014)

Viral escape in the CNS with multidrug-resistant HIV-1
por: Béguelin, Charles, et al.
Publicado: (2014)

Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load
por: Schweitzer, Finja, et al.
Publicado: (2014)

Service impact of a change in HIV-1 viral load quantification assay
por: Tipple, Craig, et al.
Publicado: (2014)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients
por: Mengoli, Carlo, et al.
Publicado: (2014)

Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting
por: Gianotti, Nicola, et al.
Publicado: (2014)

Switching to nevirapine-based regimens after undetectable viral load is not associated with increased risk of discontinuation due to toxicity
por: Patterson, Patricia, et al.
Publicado: (2014)

Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
por: Davies, Olubanke, et al.
Publicado: (2014)

L’obésité chez les patients diabétiques atteints de Covid-19 : quel pronostic ? résultats préliminaires
por: Jebali, C., et al.
Publicado: (2020)

739 A Review of Current Methicillin-Resistant Staphylococcus Aureus Decolonization Practices in a Pediatric Burn Population
por: Hockenberry, Tiffany, et al.
Publicado: (2023)

737 Burn Data Management and Usage Across Canada: A Nationwide Survey
por: Gus, Eduardo, et al.
Publicado: (2023)

740 Implementation and Retrospective Assessment of a Modified Graft Loss Grading System
por: Conner, Adam, et al.
Publicado: (2023)

738 Access to Burn Care: A 10 Year Perspective of Burn Centers in the U.S.
por: Lovick, Elle, et al.
Publicado: (2023)

736 Burn Injuries During the Pandemic: Older Patients, Delays to Admission, and Longer Hospital Stays
por: Vuillier, Jonathan, et al.
Publicado: (2023)

Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2014)

High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis
por: Reepalu, Anton, et al.
Publicado: (2014)

Four-drugs regimen containing raltegravir is highly effective in HIV patients starting therapy with >500,000 copies/mL viral load
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

DRV concentrations and viral load in CSF in patients on DRV/r 600/100 or 800/100mg once daily plus two NRTI
por: Di Yacovo, Silvana, et al.
Publicado: (2014)

Les éruptions virales aux urgences dermatologiques : étude comparative avant et après la pandémie COVID-19
por: Ben Kahla, Marouane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cphea3qm6u6qs8suq6ve13lh0r